Jump to content

Ets variant 3

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dexbot (talk | contribs) at 06:17, 28 August 2015 (Bot: Deprecating Template:Cite pmid and some minor fixations). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:PBB

Ets variant 3 is a protein that in humans is encoded by the ETV3 gene. [1]

References

  1. ^ "Entrez Gene: Ets variant 3". Retrieved 2014-09-11.

Further reading

  • Klemsz, M; Hromas, R; Raskind, W; Bruno, E; Hoffman, R (1994). "PE-1, a novel ETS oncogene family member, localizes to chromosome 1q21-q23". Genomics. 20 (2): 291–4. doi:10.1006/geno.1994.1169. PMID 8020980.
  • Hester, K. D.; Verhelle, D; Escoubet-Lozach, L; Luna, R; Rose, D. W.; Glass, C. K. (2007). "Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS". Cell cycle (Georgetown, Tex.). 6 (13): 1594–604. doi:10.4161/cc.6.13.4336. PMID 17525531.
  • Anney, R. J. L.; Lasky-Su, J.; ó'Dúshláine, C.; Kenny, E.; Neale, B. M.; Mulligan, A.; Franke, B.; Zhou, K.; Chen, W.; Christiansen, H.; Arias-Vásquez, A.; Banaschewski, T.; Buitelaar, J.; Ebstein, R.; Miranda, A.; Mulas, F.; Oades, R. D.; Roeyers, H.; Rothenberger, A.; Sergeant, J.; Sonuga-Barke, E.; Steinhausen, H.; Asherson, P.; Faraone, S. V.; Gill, M. (2008). "Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study". American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 147B (8): 1369–1378. doi:10.1002/ajmg.b.30871. PMID 18951430.
  • Sawka-Verhelle, D; Escoubet-Lozach, L; Fong, A. L.; Hester, K. D.; Herzig, S; Lebrun, P; Glass, C. K. (2004). "PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation". Journal of Biological Chemistry. 279 (17): 17772–84. doi:10.1074/jbc.M311991200. PMID 14754893.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  • Klappacher, G. W.; Lunyak, V. V.; Sykes, D. B.; Sawka-Verhelle, D; Sage, J; Brard, G; Ngo, S. D.; Gangadharan, D; Jacks, T; Kamps, M. P.; Rose, D. W.; Rosenfeld, M. G.; Glass, C. K. (2002). "An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation". Cell. 109 (2): 169–80. doi:10.1016/S0092-8674(02)00714-6. PMID 12007404.
  • Mesquita, B; Lopes, P; Rodrigues, A; Pereira, D; Afonso, M; Leal, C; Henrique, R; Lind, G. E.; Jerónimo, C; Lothe, R. A.; Teixeira, M. R. (2013). "Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes". Breast Cancer Research and Treatment. 138 (1): 37–45. doi:10.1007/s10549-013-2408-2. PMID 23329352.
  • El Kasmi, K. C.; Smith, A. M.; Williams, L.; Neale, G.; Panopoulos, A. D.; Watowich, S. S.; Häcker, H.; Foxwell, B. M.; Murray, P. J. (2007). "Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway". Journal of immunology (Baltimore, Md. : 1950). 179 (11): 7215–7219. doi:10.4049/jimmunol.179.11.7215. PMID 18025162.


Stub icon

This article on a gene on human chromosome 1 is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ets_variant_3&oldid=678248079"